PERGOVERIS Pen Inj Lös 450IE/225IE 0.72 ml
Details
- Manufacturer
- Merck (Schweiz) AG
- ATC code
- G03GA30
- Status
- 9 abgeschlossen
- Reported since
- 21 days
- First report
- 29.12.2022
- Active substance
- follitropinum alfa, lutropinum alfa
- Swissmedic no.
- 6660802
- Public price (PPUB)
- CHF 278.40
- Ex-factory price (PEXF)
- CHF 240.89
- Product information (AIPS)
- swissmedicinfo.ch →
Overview
PERGOVERIS Pen Inj Lös 450IE/225IE 0.72 ml is a medication by Merck (Schweiz) AG containing the active substance follitropinum alfa, lutropinum alfa (ATC code G03GA30). This entry is marked as resolved — the documented shortage lasted 21 days. Switzerland has 2 other products approved with the same active substance — none are currently available.
Available alternatives
No alternatives with the same active substance are currently available.
Composition
follitropinum alfa 450 U.I., lutropinum alfa 225 U.I., saccharum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas monohydricus, acidum phosphoricum aut natrii hydroxidum q.s. ad pH, poloxamerum 188, methioninum, phenolum, arginini hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 0.72 ml corresp. natrium 0.2642 mg.
Frequently asked questions
What can I do if PERGOVERIS Pen Inj Lös 450IE/225IE 0.72 ml is unavailable?▾
Contact your pharmacy or treating physician. Substitution with a product containing the same active substance (follitropinum alfa, lutropinum alfa) is often possible. Available alternatives are listed above on this page.
What alternatives exist for PERGOVERIS Pen Inj Lös 450IE/225IE 0.72 ml?▾
Available alternatives with the same active substance are listed above. follitropinum alfa, lutropinum alfa is the underlying active substance — pharmacies can dispense a generic or alternative brand after consulting with the doctor.
When will PERGOVERIS Pen Inj Lös 450IE/225IE 0.72 ml be available again?▾
The expected delivery date — if communicated by the manufacturer — is shown in the detail section on this page. Shortages in this active-substance class typically last several weeks in Switzerland. Only the manufacturer can provide a binding forecast.
Why is PERGOVERIS Pen Inj Lös 450IE/225IE 0.72 ml unavailable?▾
Common reasons include manufacturing problems, active-substance shortages, quality issues, or a planned withdrawal from the Swiss market. More detailed background — when disclosed by the manufacturer — is shown in the detail section above.
Where do I report a shortage of PERGOVERIS Pen Inj Lös 450IE/225IE 0.72 ml?▾
Shortages are officially reported to drugshortage.ch (by manufacturers and pharmacies). Patients and treating physicians can escalate the shortage through their pharmacy — which has direct access to the reporting pipeline.
Source: drugshortage.ch · no warranty of completeness